In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers

Niagara Muhammad Idris,Muthu Kumara Gnanasammandhan,Jing Zhang,Paul C Ho,Ratha Mahendran,Yong Zhang
DOI: https://doi.org/10.1038/nm.2933
IF: 82.9
2012-09-16
Nature Medicine
Abstract:A limitation of photodynamic therapy (PDT) is the depth of penetration of visible light needed for activation of the photosensitizers, restricting treatment to tumors on or just under the skin’s surface or those lining internal organs and cavities. Niagara Muhammad Idris and colleagues have addressed this issue by developing upconversion fluorescent nanoparticles (UNCs) that convert deeper penetrating near-infrared light to visible wavelengths without sacrificing efficacy for singlet oxygen (1O2) production. The group tested the UNCs in vivo in a subcutaneous mouse tumor model using a dual-sensitizer approach for greater PDT efficacy.
biochemistry & molecular biology,cell biology,medicine, research & experimental
What problem does this paper attempt to address?